Wellington Management Group LLP lessened its holdings in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 57.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 64,700 shares of the construction company's stock after selling 85,932 shares during the quarter. Wellington Management Group LLP owned 0.08% of Aspen Aerogels worth $769,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors also recently added to or reduced their stakes in ASPN. Sandia Investment Management LP purchased a new stake in shares of Aspen Aerogels during the 4th quarter worth approximately $89,000. Wealth Enhancement Advisory Services LLC purchased a new stake in shares of Aspen Aerogels during the 4th quarter worth approximately $129,000. AlphaQuest LLC boosted its stake in shares of Aspen Aerogels by 54.0% during the 4th quarter. AlphaQuest LLC now owns 11,395 shares of the construction company's stock worth $135,000 after acquiring an additional 3,998 shares in the last quarter. KLP Kapitalforvaltning AS purchased a new stake in shares of Aspen Aerogels during the 4th quarter worth approximately $164,000. Finally, Connors Investor Services Inc. purchased a new stake in shares of Aspen Aerogels during the 4th quarter worth approximately $168,000. Hedge funds and other institutional investors own 97.64% of the company's stock.
Aspen Aerogels Trading Up 1.5%
Shares of NYSE ASPN traded up $0.10 during trading on Wednesday, hitting $6.48. 1,355,366 shares of the company traded hands, compared to its average volume of 2,009,370. Aspen Aerogels, Inc. has a 1 year low of $4.16 and a 1 year high of $33.15. The company has a 50-day moving average price of $5.66 and a 200-day moving average price of $8.90. The firm has a market capitalization of $531.63 million, a P/E ratio of 40.47 and a beta of 2.68. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27.
Aspen Aerogels (NYSE:ASPN - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The construction company reported ($0.06) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.01. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. The company had revenue of $78.72 million during the quarter, compared to analysts' expectations of $82.75 million. During the same period in the previous year, the company earned ($0.02) EPS. The business's quarterly revenue was down 16.7% compared to the same quarter last year. On average, equities analysts predict that Aspen Aerogels, Inc. will post 0.17 EPS for the current year.
Analyst Upgrades and Downgrades
Several research analysts recently issued reports on the company. Craig Hallum cut their price objective on Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating for the company in a research report on Friday, February 14th. TD Cowen upgraded Aspen Aerogels to a "strong-buy" rating in a research report on Tuesday, March 11th. Seaport Res Ptn downgraded Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, February 12th. Wall Street Zen upgraded Aspen Aerogels to a "sell" rating in a research report on Wednesday, February 19th. Finally, Canaccord Genuity Group cut their price objective on Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating for the company in a research report on Friday, February 14th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $18.44.
Read Our Latest Stock Report on ASPN
Insider Activity
In other Aspen Aerogels news, CEO Donald R. Young purchased 20,000 shares of the firm's stock in a transaction that occurred on Monday, May 12th. The stock was purchased at an average cost of $5.35 per share, with a total value of $107,000.00. Following the transaction, the chief executive officer now owns 550,856 shares in the company, valued at approximately $2,947,079.60. This trade represents a 3.77% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 4.30% of the company's stock.
Aspen Aerogels Company Profile
(
Free Report)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Further Reading

Before you consider Aspen Aerogels, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.
While Aspen Aerogels currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.